Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Emily Lin

Anesthesiology New York, NY Medical Doctor

NPI 1043472046 CMS profile 1301912

620 W 42Nd St, S-37C, New York, NY 10036

Open in the dashboard

General payments

$5,499

25 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Emily Lin of New York, NY is reported in the CMS Open Payments database as having received $5,499 across 25 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $1,499 6
2020 General $1,000 1
2019 General $3,000 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Emily Lin
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Emily Lin were reported at $0. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Emily Lin Anesthesiology median Middle half National median
2019 $3,000 $72 $23–$151 $163
2020 $1,000 $36 $17–$120 $114
2021 $0 $49 $21–$135 $132
2022 $1,499 $52 $22–$144 $149
2023 $0 $53 $23–$143 $160
2024 $0 $55 $25–$150 $164
2025 $0 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Pacira Pharmaceuticals Incorporated $5,499 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Travel and Lodging $3,255 18 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 2 payments
  3. Honoraria $500 1 payment
  4. Food and Beverage $244 4 payments
Products named General payments · program years 2019–2022
  1. EXPAREL Pain Management $4,000 19 payments
  2. Exparel Pain Management $1,499 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$46,985

Medicare's payments for the services billed

Medicare patients

438

Average age 74

Services billed

470

250 women, 188 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 62%
Arthritis 49%
Diabetes 35%
Ischemic heart disease 29%
Chronic kidney disease 25%
Depression 22%
Osteoporosis 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

25 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record